Global Summit on Improving Bioavailability of Medicines 2022: Two Day Online Program – May 16-17, 2022 | News

DUBLIN, April 1, 2022 /PRNewswire/ — The “Global Summit on Improving Drug Bioavailability 2022” conference has been added to ResearchAndMarkets.comit’s offer.

Are you responsible for improving drug performance, bioavailability and patient adherence? Would you like to discover new strategies to reduce dosage, costs and reduce time to market of products?

Check out the 2022 Global Summit on Improving Drug Bioavailability program agenda and walk away with 2+ years of novel drug formulation and bioavailability improvement strategies. Learn directly from 30+ senior drug bioavailability pioneers and network with 120+ senior drug development innovators next May in Philadelphia, PA.

The 2022 2-day program features the latest in industry formulation and delivery technologies to improve solubility and maximize bioavailability. The 2022 Summit will share cutting-edge research on the development, characterization and manufacturing of formulations spanning multiple modalities.

  • Precision Medicine and Healthcare Delivery
  • Rational formulation design for poorly soluble compounds
  • In-vivo – in-vitro correlation
  • Solution behavior of amorphous solid dispersions
  • Nanosuspension to improve bioavailability
  • Early Formulation Screening in Drug Discovery
  • 3D printing for biopharma
  • Improving patient adherence via drug administration
  • Innovative strategies around drug/device combinations

2021 speakers included:

Manish Guptadoctorate

Senior Director, Pharmaceutical Development – Sterile


Dedong Wudoctorate

Senior Scientist, Solid State

Astra Zeneca

Arijit Chakravartydoctorate

Chief Executive Officer

Fractal therapy

Rick Panicuccidoctorate

Senior Vice President, CMC

Therapeutic QED

Saji Vijayandoctorate

Vice President – R&D Strategy

Endo Pharmaceuticals

Sune Andersondoctorate

Senior Scientist, Spray Drying

Johnson & Johnson

Susan Rosenbaum

Founder, CEO

Laurent Science

stephen tindaldoctorate

Director, Science and Technology

Catalent Pharmaceutical Solutions

Melanie Marotadoctorate

Associate Principal Investigator, Pharmaceutical Sciences

Merck & Co.

Eric Munsondoctorate

Patrick DeLuca Endowed Professor of Pharmaceutical Technology, Department of Pharmaceutical Sciences

Purdue University

Di Wudoctorate

Senior Scientist, Formulation Development

Merck & Co.

Stephen Sterndoctorate

Director of Research and Development, Head of the Pharmacology and Toxicology Section

Nanotechnology Characterization Laboratory

Dabing Chen, Ph.D.

Senior Principal Scientist

Boehringer Ingelheim

Xin Liudoctorate

Associate Director of Pharmaceutical Product Development


Christopher Nuboldt

Principal Investigator


Sudhakar Garaddoctorate

Global Head of Chemical and Pharmaceutical Profiling


For more information about this conference, visit

Media Contact:

Research and Markets

Laura Woodsenior

[email protected]

For EST office hours, call +1-917-300-0470

For USA/CAN call toll free +1-800-526-8630

For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907

Fax (outside the US): +353-1-481-1716

Show original content:—may-16-17-2022-301515643.html

SOURCE Research and Markets

Karen O. Fielding